S.R. Drugs And Intermediates (Unit 4) Private Limited

Conducts research and development in pharmaceuticals, natural products, and medical field.

2021 | Medak, Telangana (India) | Active
Last Updated:

S.R. Drugs And Intermediates (Unit 4) Profile

Key Indicators

  • Authorised Capital ₹ 1.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 3 Year, 10 Months
  • Last Filing with ROC 31 Mar 2024

About S.R. Drugs And Intermediates (Unit 4)

S.R. Drugs And Intermediates (Unit 4) Private Limited (SDAIU4PL) is a Private Limited Indian Non-Government Company incorporated in India on 05 May 2021 (Three years and ten months 26 days old ). Its registered office is in Medak, Telangana, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.

Satyanarayana Chinnamail and Satyanarayana Khairtabad serve as directors at the Company.

Company Details

  • Location

    Medak, Telangana, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24290TG2021PTC151180

  • Company No.

    151180

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    05 May 2021

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Hyderabad

Industry

Pharma

Who are the key members and board of directors at S.R. Drugs And Intermediates (Unit 4)?

Board Members (2)

NameDesignationAppointment DateStatus
Satyanarayana Chinnamail Country flag representing In Director 05-May-2021Current
Satyanarayana Khairtabad Country flag representing In Director 05-May-2021Current

Financial Performance of S.R. Drugs And Intermediates (Unit 4).

S.R. Drugs And Intermediates (Unit 4) Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

S.R. Drugs And Intermediates (Unit 4) revenue growth over time
S.R. Drugs And Intermediates (Unit 4) profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
Revenue from Operations
Total Assets
Profit or Loss
Net Worth
EBITDA

What is the Ownership and Shareholding Structure of S.R. Drugs And Intermediates (Unit 4)?

Unlock access to S.R. Drugs And Intermediates (Unit 4)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at S.R. Drugs And Intermediates (Unit 4)?

S.R. Drugs And Intermediates (Unit 4) has a workforce of 0 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for S.R. Drugs And Intermediates (Unit 4) Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of S.R. Drugs And Intermediates (Unit 4), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped S.R. Drugs And Intermediates (Unit 4)'s trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on S.R. Drugs And Intermediates (Unit 4)

Recent activity within the organization

  • Annual General Meeting

    S.R. Drugs And Intermediates (Unit 4) Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

  • Balance Sheet

    S.R. Drugs And Intermediates (Unit 4) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.

  • Director Appointment

    Satyanarayana Reddy Chinnamail was appointed as a Director was appointed as a Director on 05 May 2021 & has been associated with this company since 3 years 10 months .

  • Director Appointment

    Satyanarayana Reddy Khairtabad was appointed as a Director was appointed as a Director on 05 May 2021 & has been associated with this company since 3 years 10 months .

  • Company Incorporation

    S.R. Drugs And Intermediates (Unit 4) Private Limited was registered on 05 May 2021 with Roc Hyderabad & aged 3 years 10 months as per MCA records.

Frequently asked questions

  • What is the Incorporation or founding date of S.R. Drugs And Intermediates (Unit 4) Private Limited?

    S.R. Drugs And Intermediates (Unit 4) Private Limited was incorporated on 05 May 2021.

  • What is authorized share capital and paid-up capital of S.R. Drugs And Intermediates (Unit 4) Private Limited?

    The authorized share capital of S.R. Drugs And Intermediates (Unit 4) Private Limited is ₹ 1.50 M and paid-up capital is ₹ 0.10 M.

  • Who are the current board members & directors of S.R. Drugs And Intermediates (Unit 4) Private Limited?

    Currently 2 directors are associated with S.R. Drugs And Intermediates (Unit 4) Private Limited.

    • Satyanarayana Reddy Chinnamail
    • Satyanarayana Reddy Khairtabad

  • What is the registered address of S.R. Drugs And Intermediates (Unit 4) Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of S.R. Drugs And Intermediates (Unit 4) Private Limited is H. No. 3-58 S.R. Chambers Main Road Ramachandrapuram, Medak India, Hyderabad, Telangana, 502032.

  • What is the corporate identification number (CIN) and company number of S.R. Drugs And Intermediates (Unit 4) Private Limited?

    The corporate identification number (CIN) of S.R. Drugs And Intermediates (Unit 4) Private Limited is U24290TG2021PTC151180 and the company number is 151180 as per Ministry of Corporate Affairs (MCA).

  • When was the last Balance Sheet of S.R. Drugs And Intermediates (Unit 4) Private Limited filed with the ROC?

    The most recent Balance Sheet for S.R. Drugs And Intermediates (Unit 4) Private Limited was filed with the ROC on 31 Mar 2024.